| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |